Literature DB >> 27465668

The use of serum anti-Mullerian hormone (AMH) levels and antral follicle count (AFC) to predict the number of oocytes collected and availability of embryos for cryopreservation in IVF.

L Kotanidis1,2, K Nikolettos3, S Petousis4, B Asimakopoulos5, E Chatzimitrou6, G Kolios7, N Nikolettos8,3.   

Abstract

AIM: To investigate the predictive value of anti-Mullerian hormone (AMH) and antral follicle count (AFC) on the final number of oocytes retrieved and the availability of embryos for cryopreservation in in vitro fertilization (IVF) cycles. PATIENTS AND METHODS: In this prospective study, one hundred and twenty women in their first IVF treatment were enrolled. The short stimulation agonist protocol was used for controlled ovarian hyperstimulation in all cases. Serum AMH levels were measured during the menstrual cycle preceding treatment. AFC was measured in cycle day 2, just before starting ovarian stimulation.
RESULTS: A strong, positive correlation between AMH, AFC and the number of collected oocytes was found. The patients with available and suitable supplementary embryos for cryopreservation had higher levels of AMH and larger numbers of AFC.
CONCLUSION: AMH and AFC appear to be valuable markers mainly for ovarian reserve and response to IVF treatment. Serum AMH levels and AFC are significantly associated with the number of retrieved oocytes. Also, a positive correlation with the availability of supernumerary embryos suitable for cryopreservation was observed.

Entities:  

Keywords:  AFC; AMH; Cryopreservation; Embryos; IVF; Oocytes

Mesh:

Substances:

Year:  2016        PMID: 27465668     DOI: 10.1007/s40618-016-0521-x

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  33 in total

1.  Predictive factors of ovarian response and clinical outcome after IVF/ICSI following a rFSH/GnRH antagonist protocol with or without oral contraceptive pre-treatment.

Authors:  A Nyboe Andersen; H Witjes; K Gordon; B Mannaerts
Journal:  Hum Reprod       Date:  2011-09-27       Impact factor: 6.918

2.  Antimüllerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracyoplasmic sperm injection.

Authors:  Jesper M J Smeenk; Fred C G J Sweep; Gerhard A Zielhuis; Jan A M Kremer; Chris M G Thomas; Didi D M Braat
Journal:  Fertil Steril       Date:  2006-11-01       Impact factor: 7.329

Review 3.  Developmental and endocrine aspects of normal ovarian aging.

Authors:  E R te Velde; G J Scheffer; M Dorland; F J Broekmans; B C Fauser
Journal:  Mol Cell Endocrinol       Date:  1998-10-25       Impact factor: 4.102

4.  Antral follicle count determines poor ovarian response better than anti-Müllerian hormone but age is the only predictor for live birth in in vitro fertilization cycles.

Authors:  Mehmet Firat Mutlu; Mehmet Erdem; Ahmet Erdem; Sule Yildiz; Ilknur Mutlu; Ozgur Arisoy; Mesut Oktem
Journal:  J Assist Reprod Genet       Date:  2013-03-19       Impact factor: 3.412

5.  Using anti-Müllerian hormone to identify a good prognosis group in women of advanced reproductive age.

Authors:  Barbro Fridén; Peter Sjöblom; Judith Menezes
Journal:  Aust N Z J Obstet Gynaecol       Date:  2011-10       Impact factor: 2.100

6.  Serum anti-Mullerian hormone levels correlate with ovarian response in idiopathic hypogonadotropic hypogonadism.

Authors:  M Sönmezer; B Özmen; C S Atabekoglu; E G Papuccu; S Ozkavukcu; B Berker; R Pabuccu
Journal:  J Assist Reprod Genet       Date:  2012-05-01       Impact factor: 3.412

7.  Anti-Müllerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology.

Authors:  A La Marca; S Giulini; A Tirelli; E Bertucci; T Marsella; S Xella; A Volpe
Journal:  Hum Reprod       Date:  2006-10-27       Impact factor: 6.918

8.  [Estimation of ovarian response using multiple predictors of ovarian reserve in women undergoing in vitro fertilization-embryo transfer].

Authors:  Yuxia He; Rong Xia; Xin Chen; Desheng Ye; Yan Tang; Pu Li; Jing Niu; Shiling Chen
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2013-02

9.  Anti-müllerian hormone is a promising predictor for the occurrence of the menopausal transition.

Authors:  Ilse A J van Rooij; Isolde den Tonkelaar; Frank J M Broekmans; Caspar W N Looman; Gabrielle J Scheffer; Frank H de Jong; Axel P N Themmen; Egbert R te Velde
Journal:  Menopause       Date:  2004 Nov-Dec       Impact factor: 2.953

10.  Bivariate analysis of basal serum anti-Müllerian hormone measurements and human blastocyst development after IVF.

Authors:  E Scott Sills; Gary S Collins; Adam C Brady; David J Walsh; Kevin D Marron; Alison C Peck; Anthony P H Walsh; Rifaat D Salem
Journal:  Reprod Biol Endocrinol       Date:  2011-12-02       Impact factor: 5.211

View more
  5 in total

1.  Long-term hormonal contraceptive use is associated with a reversible suppression of antral follicle count and a break from hormonal contraception may improve oocyte yield.

Authors:  Joseph M Letourneau; Hakan Cakmak; Molly Quinn; Nikita Sinha; Marcelle I Cedars; Mitchell P Rosen
Journal:  J Assist Reprod Genet       Date:  2017-07-01       Impact factor: 3.412

2.  Back-to-back random-start ovarian stimulation prior to chemotherapy to maximize oocyte yield.

Authors:  Kaitlyn Wald; Hakan Cakmak; Evelyn Mok-Lin; Marcelle Cedars; Mitchell Rosen; Joseph Letourneau
Journal:  J Assist Reprod Genet       Date:  2019-05-24       Impact factor: 3.412

3.  A novel mathematical model of true ovarian reserve assessment based on predicted probability of poor ovarian response: a retrospective cohort study.

Authors:  Huiyu Xu; Guoshuang Feng; Haiyan Wang; Yong Han; Rui Yang; Ying Song; Lixue Chen; Li Shi; Meng Qian Zhang; Rong Li; Jie Qiao
Journal:  J Assist Reprod Genet       Date:  2020-04-21       Impact factor: 3.412

4.  Age-specific reference values and cut-off points for anti-müllerian hormone in infertile women following a long agonist treatment protocol for IVF.

Authors:  Z Heidar; M Bakhtiyari; F Foroozanfard; M Mirzamoradi
Journal:  J Endocrinol Invest       Date:  2017-12-12       Impact factor: 4.256

5.  The Predictive Levels of Serum Anti-Müllerian Hormone and the Combined Index of the Number of Retrieved Oocytes and Good-Quality Embryos in Advanced-Age Infertile Women.

Authors:  Tie-Cheng Sun; Xi Chen; Cheng Shi; Li Tian; Shan-Jie Zhou
Journal:  Int J Endocrinol       Date:  2022-04-18       Impact factor: 2.803

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.